SPS
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome (NCT06588491) | Kyverna Therapeutics | 2024-09-25 |
Track SPS automatically
Every clearance here is in the API, with alerts when new ones post.